Published in Eur J Surg Oncol on January 10, 2012
S-100B Protein and Chronic Subdural Hematoma. Front Neurol (2013) 1.09
Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression. Oncotarget (2016) 0.81
Tyrosinase-related protein 1 mRNA expression in lymph node metastases predicts overall survival in high-risk melanoma patients. Br J Cancer (2013) 0.81
Prognostic value of melanoma inhibitory activity protein in localized cutaneous malignant melanoma. J Skin Cancer (2014) 0.76
Risk Factors for Positive Deep Pelvic Nodal Involvement in Patients with Palpable Groin Melanoma Metastases: Can the Extent of Surgery be Safely Minimized? : A Retrospective, Multicenter Cohort Study. Ann Surg Oncol (2015) 0.75
Anti-melanoma activity of Forsythiae Fructus aqueous extract in mice involves regulation of glycerophospholipid metabolisms by UPLC/Q-TOF MS-based metabolomics study. Sci Rep (2016) 0.75
Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. J Clin Oncol (1996) 2.61
Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med (2000) 2.19
[Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up]. Ned Tijdschr Geneeskd (2008) 2.06
Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol (2007) 1.98
Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis. Eur J Surg Oncol (1995) 1.90
The effect of surgical wounding on tumour development. Eur J Surg Oncol (1999) 1.88
Early development of the metabolic syndrome after chemotherapy for testicular cancer. Ann Oncol (2012) 1.70
Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins. J Clin Oncol (2000) 1.62
The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer Treat Rev (2004) 1.60
Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma. Eur J Surg Oncol (2002) 1.54
Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.52
Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study. Ann Oncol (2004) 1.52
Continuous leakage measurement during hyperthermic isolated limb perfusion. Ann Surg Oncol (2001) 1.49
Comparison of cytogenetic abnormalities and deoxyribonucleic acid ploidy of benign, borderline malignant, and different grades of malignant soft tissue tumors. Lab Invest (1994) 1.44
Imaging of soft-tissue tumors using L-3-[iodine-123]iodo-alpha-methyl-tyrosine single photon emission computed tomography: comparison with proliferative and mitotic activity, cellularity, and vascularity. Clin Cancer Res (2000) 1.42
Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol (2003) 1.41
Predicting postoperative mortality after colorectal surgery: a novel clinical model. Colorectal Dis (2014) 1.41
[Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients]. Ned Tijdschr Geneeskd (2005) 1.39
[Myositis as the first manifestation of an exacerbation of Crohn's disease]. Ned Tijdschr Geneeskd (2007) 1.39
Groin dissection in the treatment of lower-extremity melanoma. Short-term and long-term morbidity. Arch Surg (1992) 1.38
Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. Eur J Surg Oncol (2006) 1.33
Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol (2004) 1.31
Genetic predisposition to testicular germ-cell tumours. Lancet Oncol (2004) 1.28
Epiphyseal fractures in children treated for osteosarcoma of the femur with chemotherapy, tumourresection, and endoprosthesis: report of four fractures in two children. J Surg Oncol (1984) 1.28
Prevalence of paraneoplastic hyperthyroidism in patients with metastatic non-seminomatous germ-cell tumors. Ann Oncol (2009) 1.25
Limb salvage surgery for primary bone sarcoma of the lower extremities: long-term consequences of endoprosthetic reconstructions. Ann Surg Oncol (1998) 1.24
Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 1.23
Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg (1998) 1.22
Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol (2006) 1.21
Detection of unknown occult primary tumors using positron emission tomography. Cancer (1998) 1.18
Aggressive fibromatosis (non-familial desmoid tumour): therapeutic problems and the role of adjuvant radiotherapy. Br J Surg (1995) 1.17
Familial testicular cancer in a single-centre population. Eur J Cancer (1999) 1.17
Long-term prognosis of primary retroperitoneal soft tissue sarcoma. Eur J Surg Oncol (2006) 1.15
External and internal hemipelvectomy for sarcomas of the pelvic girdle: consequences of limb-salvage treatment. Eur J Surg Oncol (1997) 1.15
Locoregional recurrence of retroperitoneal soft tissue sarcoma: second chance of cure for selected patients. Eur J Surg Oncol (2001) 1.13
Sexual functioning after treatment for testicular cancer--review and meta-analysis of 36 empirical studies between 1975-2000. Arch Sex Behav (2001) 1.13
Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma. J Nucl Med (1996) 1.11
Chromosomal analysis and the classification of soft tissue sarcomas. Lab Invest (1989) 1.10
Soft tissue sarcoma--compliance with guidelines. Cancer (2001) 1.04
Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. Surg Oncol (2006) 1.04
Asymptomatic pseudotumours after metal-on-metal hip resurfacing show little change within one year. Bone Joint J (2013) 1.03
The effect of chemotherapy on the growing skeleton. Cancer Treat Rev (2000) 1.03
Osteosarcoma of the pelvis--oncological results of 40 patients registered by The Netherlands Committee on Bone Tumours. Eur J Surg Oncol (2000) 1.01
Dermatofibrosarcoma protuberans: recurrence is related to the adequacy of surgical margins. Eur J Surg Oncol (2009) 1.01
Therapeutic groin dissection for melanoma: risk factors for short term morbidity. Eur J Surg Oncol (2008) 1.01
Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer. Eur J Cancer (2004) 0.99
Clinico-pathological data and prognostic factors in completely resected AJCC stage I-III liposarcomas. Ann Surg Oncol (2000) 0.99
Current treatment for colorectal cancer metastatic to the liver. Eur J Surg Oncol (1999) 0.98
Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma. Eur J Surg Oncol (2003) 0.98
Repeated resection of recurrent pulmonary metastatic soft tissue sarcoma. Eur J Surg Oncol (1994) 0.97
Frozen section analysis of sentinel lymph nodes in melanoma patients. Cancer (2000) 0.97
Quality of life of testicular cancer survivors and the relationship with sociodemographics, cancer-related variables, and life events. Support Care Cancer (2005) 0.96
Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up: a single-center 10-year experience. J Clin Oncol (1995) 0.96
Cytogenetics of a case of eccrine spiradenoma. Hum Pathol (1992) 0.95
Survival of metal-on-metal hip resurfacing arthroplasty: a systematic review of the literature. J Bone Joint Surg Br (2011) 0.95
Family functioning and adolescents' emotional and behavioral problems: when a parent has cancer. Ann Oncol (2007) 0.95
Image guided surgery: new technology for surgery of soft tissue and bone sarcomas. Eur J Surg Oncol (2006) 0.94
Geographical distribution of publications in the scientific field of surgical oncology. J Surg Oncol (2013) 0.94
Angiographic response of locally advanced soft-tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor. Ann Surg Oncol (1997) 0.93
Epidemiological aspects of soft tissue sarcomas (STS)--consequences for the design of clinical STS trials. Eur J Cancer (1999) 0.92
Recurrent, multiple, calcified soft tissue metastases from osteogenic sarcoma without pulmonary involvement. Skeletal Radiol (1999) 0.92
Follow-up schedules after treatment for malignant melanoma. Br J Surg (2008) 0.92
Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in patients with locally advanced soft tissue sarcomas: treatment response and clinical outcome related to changes in proliferation and apoptosis. Clin Cancer Res (1999) 0.92
Osteosarcoma of the sternum. Eur J Surg Oncol (1997) 0.92
Fluorine-18-fluorodeoxyglucose assessment of glucose metabolism in bone tumors. J Nucl Med (1998) 0.92
Historical, current and future aspects of osteosarcoma treatment. Eur J Surg Oncol (1998) 0.91
Complications of venous access ports in 132 patients with disseminated testicular cancer treated with polychemotherapy. J Clin Oncol (1996) 0.91
Surgical treatment of pulmonary metastases from soft tissue sarcomas: a retrospective study in The Netherlands. J Surg Oncol (1994) 0.91
Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications. Cancer Treat Rev (2004) 0.91
Impact of [18F]fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients. Br J Surg (2006) 0.91
Palliative and curative electrocoagulation for rectal cancer. Experience and results. Cancer (1985) 0.90
S-100B concentrations predict disease-free survival in stage III melanoma patients. Ann Surg Oncol (2009) 0.90
Sarcoid reaction mimicking intrathoracic dissemination of testicular cancer. Cancer (1990) 0.89
Left ventricular and cardiac autonomic function in survivors of testicular cancer. Eur J Clin Invest (2005) 0.89
Sexual functioning after treatment for testicular cancer: comparison of treatment modalities. Cancer (1997) 0.89
Long-term follow-up reveals that ulceration and sentinel lymph node status are the strongest predictors for survival in patients with primary cutaneous melanoma. Eur J Surg Oncol (2011) 0.89
Cytogenetics of fine needle aspiration biopsies of sarcomas. Cancer Genet Cytogenet (1995) 0.89
The quality of communication between parents and adolescent children in the case of parental cancer. Ann Oncol (2005) 0.89
Soft tissue sarcoma: the predominant primary malignancy in the retroperitoneum. Sarcoma (2001) 0.89
The effect of chemotherapy on the morphology of the growth plate and metaphysis of the growing skeleton. Eur J Surg Oncol (2003) 0.89
Computer-assisted cytogenetic analysis of 51 malignant peripheral-nerve-sheath tumors: sporadic vs. neurofibromatosis-type-1-associated malignant schwannomas. Int J Cancer (1999) 0.87
Geographic clustering of testicular cancer incidence in the northern part of The Netherlands. Br J Cancer (1999) 0.87
Sexual dysfunction in nonseminoma testicular cancer patients is related to chemotherapy-induced angiopathy. J Clin Oncol (1997) 0.87
The management of clear cell sarcoma. Eur J Surg Oncol (2003) 0.87
Bilateral testicular germ cell tumours in patients with initial stage I disease: prevalence and prognosis--a single centre's 30 years' experience. Eur J Cancer (1998) 0.87
The value of high-dose methotrexate-based neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone. J Clin Oncol (1996) 0.86
Re-analysis of the Xq27-Xq28 region suggests a weak association of an X-linked gene with sporadic testicular germ cell tumour without cryptorchidism. Eur J Cancer (2006) 0.86
Feasibility and efficacy of external beam radiotherapy after hyperthermic isolated limb perfusion with TNF-alpha and melphalan for limb-saving treatment in locally advanced extremity soft-tissue sarcoma. Int J Radiat Oncol Biol Phys (1998) 0.86
The use of the saddle prosthesis for reconstruction of the hip joint after tumor resection of the pelvis. J Surg Oncol (1992) 0.86
The changing distribution of stage in nonseminomatous testicular germ cell tumours, from 1977 to 1996. BJU Int (1999) 0.86
Epithelioid sarcoma or malignant rhabdoid tumor of soft tissue? Epithelioid immunophenotype and rhabdoid karyotype. Hum Pathol (1989) 0.86
Detection of local recurrence of soft-tissue sarcoma with positron emission tomography using [18F]fluorodeoxyglucose. Ann Surg Oncol (1997) 0.85
Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities: a multicenter study. Arch Surg (1999) 0.85
Effect of single chemotherapeutic agents on the growing skeleton of the rat. Ann Oncol (2000) 0.85
Sentinel node biopsy as a surgical staging method for solid cancers. Radiother Oncol (1999) 0.85
Adolescent melanoma: risk factors and long term survival. Eur J Surg Oncol (2006) 0.85
Doxorubicin potentiates TRAIL cytotoxicity and apoptosis and can overcome TRAIL-resistance in rhabdomyosarcoma cells. Int J Oncol (2004) 0.84